• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ February 2, 2023 ] XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease News Feed
  • [ January 31, 2023 ] Zerify Starts The Year Off Strong News Feed
  • [ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
  • [ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
  • [ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
  • [ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed
HomePopular

Popular

News Feed

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

January 23, 2023 The Wall Street Analyzer 0

Safe and Effective Dosing of XORLO™ […]

News Feed

Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies

January 18, 2023 The Wall Street Analyzer 0

ANN ARBOR, MI / ACCESSWIRE / January 18, 2023 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced a strategic restructuring of […]

News Feed

Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer

January 9, 2023 The Wall Street Analyzer 0

CARLSBAD, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary […]

News Feed

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

December 29, 2022 The Wall Street Analyzer 0

The AcQForce Flutter clinical study was submitted to the FDA as part of Acutus’ PMA submission for the AcQBlate Force Sensing Ablation Catheter […]

News Feed

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

December 12, 2022 The Wall Street Analyzer 0

Drug Candidate, CQ-001 (cannabidiol “CBD” + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.
[…]

News Feed

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

November 29, 2022 The Wall Street Analyzer 0

XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial […]

News Feed

Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash

November 15, 2022 The Wall Street Analyzer 0

ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for […]

News Feed

SCOTTIE RESOURCES EXTENDS STRIKE OF BLUEBERRY CONTACT ZONE TO 1.45 KILOMETERS AND REPORTS INTERCEPT OF 4.24 G/T GOLD OVER 16.95 METRES

November 9, 2022 The Wall Street Analyzer 0

VANCOUVER, BC, Nov. 8, 2022 /CNW/ – Scottie Resources Corp. (“Scottie” or the “Company“) (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is pleased to report new assays on its Blueberry Contact Zone including an intercept of 20.3 g/t gold […]

News Feed

Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results

November 4, 2022 The Wall Street Analyzer 0

IRVINE, CA / ACCESSWIRE / November 3, 2022 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 first quarter ended September 30, 2022. The Company also filed its Quarterly Report on Form 10-Q […]

News Feed

Knightscope Completes Acquisition of CASE Emergency Systems

October 21, 2022 The Wall Street Analyzer 0

Public Safety Innovator Accelerates Growth Nationwide […]

Posts navigation

1 2 … 7 »

Featured Companies

CEO Interviews

Zomedica Corp. (NYSE American: ZOM)

November 29, 2022 0

Interview update with Larry Heaton, CEO and President […]

CEO Interviews

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 0

Interview with David Roman, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 18, 2022 0

Interview with Mark Kay, CEO and Chairman […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

Interview update with Dr. Allen Davidoff, CEO
[…]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

Interview with Rick Van Kirk, CEO […]

News Wire

  • XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
    February 2, 2023 0
  • Zerify Starts The Year Off Strong
    January 31, 2023 0
  • SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE
    January 26, 2023 0
  • Zomedica to Participate in the Lytham Partners Investor Select Conference
    January 24, 2023 0
  • XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
    January 23, 2023 0
  • Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
    January 18, 2023 0
  • SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS
    January 17, 2023 0




Follow on Facebook

About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]

Testimonials
Testimonials

Client Testimonials:

June 1, 2020 Comments Off on Client Testimonials:

“What we like most about the wallstreetanalyzer.com was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com